Manickam Vijayprakash, Periyasamy Madhivadhani, Dhakshinamoorthy Vasanth, Panneerselvam Lakshmikanthan, Perumal Ekambaram
Molecular Toxicology Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore, 641046, Tamil Nadu, India.
Molecular Toxicology Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore, 641046, Tamil Nadu, India.
Chem Biol Interact. 2017 Dec 25;278:54-64. doi: 10.1016/j.cbi.2017.10.003. Epub 2017 Oct 6.
The cardiotoxicity of iron oxide nanoparticles (FeO-NPs) in mice was investigated. The mice were intraperitoneally administered with FeO-NPs at the dose of 25 and 50 mg/kg bw for 30 days at seven days interval. In vivo MRI analysis reveals the FeO-NPs accumulation in the cardiac system. Also, serum iron estimation and Prussian blue staining confirms the iron deposition in circulatory system. Cardiac dysfunction was assessed by ECG analysis and further validated by evaluating the functional markers such as cardiac Troponin-1 (cTnI) expression, AChE activity and levels of LDH and CK-MB in cardiac tissue. FeO-NPs exposure disturbs the balance between the oxidants and antioxidants resulting in oxidative myocardial damages. In consequence, damaged mitochondria, diminished ATP level and NOX4 over expression were observed in the intoxicated groups indicating the role of FeO-NPs in oxidative stress. A dose dependant increase in oxidative stress mediates apoptosis through upregulation of Bax, cytochrome c and cleaved caspase 3 in the 25 mg/kg treated group. Sustained oxidative stress suggest the occurrence of necrosis in addition to apoptosis in 50 mg/kg treated group evidenced by altered expression pattern of cleaved PARP, cytochrome c, Bax and cleaved caspase 3. In addition, triphenyl tetrazolium chloride (TTC) staining confirms cardiac necrosis in 50 mg/kg FeO-NPs treated group.
研究了氧化铁纳米颗粒(FeO-NPs)对小鼠的心脏毒性。小鼠以25和50mg/kg体重的剂量腹腔注射FeO-NPs,每隔7天注射一次,共注射30天。体内MRI分析显示FeO-NPs在心脏系统中积累。此外,血清铁测定和普鲁士蓝染色证实了循环系统中的铁沉积。通过心电图分析评估心脏功能障碍,并通过评估心脏组织中的心脏肌钙蛋白-1(cTnI)表达、乙酰胆碱酯酶活性以及乳酸脱氢酶(LDH)和肌酸激酶同工酶(CK-MB)水平等功能标志物进行进一步验证。暴露于FeO-NPs会破坏氧化剂和抗氧化剂之间的平衡,导致心肌氧化损伤。因此,在中毒组中观察到线粒体受损、ATP水平降低和NOX4过表达,表明FeO-NPs在氧化应激中的作用。在25mg/kg治疗组中,氧化应激的剂量依赖性增加通过上调Bax、细胞色素c和裂解的半胱天冬酶3介导细胞凋亡。持续的氧化应激表明,在50mg/kg治疗组中,除了细胞凋亡外还发生了坏死,这通过裂解的聚(ADP-核糖)聚合酶(PARP)、细胞色素c、Bax和裂解的半胱天冬酶3的表达模式改变得到证实。此外,氯化三苯基四氮唑(TTC)染色证实了50mg/kg FeO-NPs治疗组的心脏坏死。